- Home
- GOOGM vs JNJ Comparison
GOOGM vs JNJ Comparison
Compare GOOGM & JNJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
GOOGM
Alphabet Inc. Depositary Shares representing a 1/20th Interest in a Share of Series A Mandatory Convertible Preferred Stock
Current Price
$48.85
HOLD
Current Price
$271.11
Company Overview
Basic Information| Metric | GOOGM | JNJ |
|---|---|---|
| Founded | N/A | 1886 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 624.3B | 542.4B |
| IPO Year | 2015 | 2003 |
Fundamental Metrics
Financial Performance| Metric | GOOGM | JNJ |
|---|---|---|
| Price | $48.85 | $271.11 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 20 |
| Target Price | N/A | ★ $238.20 |
| AVG Volume (30 Days) | 1.0M | ★ 6.8M |
| Earning Date | N/A | 04-14-2026 |
| Dividend Yield | N/A | ★ 2.36% |
| EPS Growth | 34.45 | ★ 90.50 |
| EPS | ★ 14.24 | 4.41 |
| Revenue | ★ $402,836,000,000.00 | N/A |
| Revenue This Year | N/A | $6.63 |
| Revenue Next Year | N/A | $7.43 |
| P/E Ratio | ★ $3.44 | $59.49 |
| Revenue Growth | ★ 15.09 | N/A |
| 52 Week Low | $46.24 | $173.33 |
| 52 Week High | $53.13 | $274.90 |
Technical Indicators
Market Signals| Indicator | GOOGM | JNJ |
|---|---|---|
| Relative Strength Index (RSI) | 45.49 | 66.32 |
| Support Level | $48.45 | $247.97 |
| Resistance Level | $52.44 | $272.16 |
| Average True Range (ATR) | 1.01 | 5.16 |
| MACD | -0.14 | 0.35 |
| Stochastic Oscillator | 16.28 | 93.85 |
Price Performance
Historical Comparison GOOGM
JNJ
About JNJ Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.